Immunodeficiency. Introduction



Similar documents
specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Chapter 43: The Immune System

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

Name (print) Name (signature) Period. (Total 30 points)

Antibody Structure, and the Generation of B-cell Diversity CHAPTER 4 04/05/15. Different Immunoglobulins

T Cell Maturation,Activation and Differentiation

B Cells and Antibodies

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Microbiology AN INTRODUCTION EIGHTH EDITION

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Core Topic 2. The immune system and how vaccines work

Antibody Function & Structure

The Immune System: A Tutorial

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.

Severe Combined Immune Deficiency (SCID)

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

2) Macrophages function to engulf and present antigen to other immune cells.

Transient Hypogammaglobulinemia of Infancy. Chapter 7

Why use passive immunity?

B cell activation and Humoral Immunity

The Body s Defenses CHAPTER 24

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Viral Replication. Viral Replication: Basic Concepts

Basics of Immunology

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

B Cell Generation, Activation & Differentiation. B cell maturation

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Viral Infection: Receptors

The Case of Baby Joe by Kristen L.W. Walton Page 1

Activation and effector functions of HMI

Welcome to Mini Med School at the Child & Family Research Institute

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

Autoimmunity and immunemediated. FOCiS. Lecture outline

BioMmune Technologies Inc. Corporate Presentation 2015

Chapter 3. Immunity and how vaccines work

Immunology Ambassador Guide (updated 2014)

Immunity and how vaccines work

Cytotoxic T Lymphocytes (CTLs) and NK Cells. Effector T cells. After activation, naïve T cells differentiate into effector and memory T cells

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

Immunology and immunotherapy in allergic disease

TABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

Principles of Vaccination

Chapter 5: Organization and Expression of Immunoglobulin Genes

Immuno-Oncology Therapies to Treat Lung Cancer

7.012 Quiz 3 practice

Mechanical barriers are a crucial first line of defence. It would be impossible to provide an exhaustive list. Two examples are:

Effector Mechanisms of Humoral Immunity

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

Essentials of Anatomy and Physiology, 5e (Martini/Nath) Chapter 14 The Lymphoid System and Immunity. Multiple-Choice Questions

Chapter 18: Applications of Immunology

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Immunosuppressive drugs

A Genetic Analysis of Rheumatoid Arthritis

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Problem Set 6 KEY

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment

Immunology. B lymphocytes & Antibodies , Ruhr-Universität Bochum Marcus Peters, marcus.peters@rub.de

Selective IgA deficiency (slgad)

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

Special report. Chronic Lymphocytic Leukemia (CLL) Genomic Biology 3020 April 20, 2006

I B2.4. Design of the patient information leaflet for VariQuin

CHAPTER 9 IMMUNOGLOBULIN BIOSYNTHESIS

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

Cytotoxic and Biotherapies Credentialing Programme Module 2

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Practice parameter. PREFACE The purpose of this Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency is to provide the

Pathophysiology of the human immunodeficiency virus

The immune system and HIV

Principles of Vaccination

SYMPOSIUM. June 15, Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA Boston University

Applications of Ab Molecules. Chapter 4 Monoclonal Ab (p.99) Chapter 5 Ab genes and Ab Engineering (p.128)

The Human Immune System

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

Hypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.

Lymphomas after organ transplantation

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Structure and Function of DNA

Disclosures. I have no disclosures.

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

Leukemias and Lymphomas: A primer

Cytotoxic T lymphocytes and natural killer cells

Some terms: An antigen is a molecule or pathogen capable of eliciting an immune response

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

The immune response Antibodies Antigens Epitopes (antigenic determinants) the part of a protein antigen recognized by an antibody Haptens small

Transcription:

Immunodeficiency Laura Carceles Campbell Lawson Liam Edward O'Hara Chiho Okada Maureen Elizabeth Esme Roach Andrew Forbes Robertson Emma Clare Rogers Introduction Immunodeficiency results from the absence or failure of normal function of one or more elements of the immune system. Primary Immunodeficiency Secondary Immunodeficiency 1

Primary Immunodeficiency B cell immunodeficiency X-linked agammaglobulinemia IgA deficiency Ig subclass deficiencies Common variable immunodeficiency BLNK deficiency Severe Combined Immunodeficiency IL-2 receptor gamma chain deficiency Adenosine deaminase deficiency Purine nucleoside phosphate deficiency JAK3 deficiency Recombination activating gene (RAG) 1 and 2 deficiencies Omenn Syndrome Hyper IgM syndrome Zap 70 deficiencies CD3 sub unit deficiencies X linked lyphoproliferative disease Interferon gamma receptor deficiencies Major Histocompatibility complex class I and class II deficiencies B cell development 2

X- Linked agammaglobulinemia XLA Congenital defect 1 in 100,000 male newborns. No B cells No IgA, IgM,IgD, IgE, small amount of IgG for 1st 6-12 months via maternal placenta. Recurrent pyogenic infections Have to be infused with large amounts of immunoglobulin to remain healthy. Btk gene missense mutation Bruton s Tyrosine Kinase Signalling molecule B-cell development into anti-body producing plasma cells 5 domains all of which can be affected by disease causing alterations. 3

XLA - summary Btk gene mutation Loss of functional tyrosine kinase Blocked B cell maturation No antibodies produced Severe Combined Immunodeficiencies (SCIDs) SCID a hetergenous group of monogenic disorders Characterised by: Early on-set (1 in 75,000 births) Severe infections by a full range of pathogens 20 genetic defects identified Genetic defect: Lies in T-cell differentiation Indirect impairment of B-cell function & development 4

SCIDs Types SCID Defect in: Cytokine signalling T-cell receptor signalling Receptor gene recombination Nucleotide salvage pathway MHC-I expression MHC-II expression Other Genetic Lesions IL2RG, IL2RA, IL7RA, JAK3 PTPRC, CD3G, CD3E, ZAP70 RAG1, RAG2 ADA, NP TAP1, TAP2 MHC2TA, RFXANK, RFX5, RFAXAP WASP Source: Bonilla, F.A. & Geha, R.F., (2003), Primary Immunodeficiency Diseases J Allergy Clin Immol Vol. 111(2) pp571-579 X-Linked SCID Most common form: 3:1 male:female Defect in IL2RG gene Defect in Cytokine receptor (γ c ) affecting: Receptors of IL-2, IL- 4 IL-7, IL-9, IL-15 & IL-21 Absent T-cells, normal / raised B-cells: IgM IL-7 cytokine important for T-cell maturation 5

γ c dependent cytokines in T-cell Development Malek, T.R., Porter, B. & You-Wen, H., (1999) Multiple γc-dependent cytokines regulate T-cell development Immunology Today, Vol. 20(2) pp71-76 SCID ADAD Adenosine Deaminase Deficiency Autosomally recessive 15% of SCIDs Defect in salvage pathway Accumulation of toxic datp and dgtp Inhibition of ribonucleotide reductase Impaired development and lifespan of: T-cells & B-cells 6

ADAD & PNPD Mechanism SCID Impaired Ca 2+ flux Defect in nuclear translocation of nuclear factor of activated T-cells (NFAT) T-cell development normal Impaired proliferation in response to activation Defective Ca 2+ influx via calcium regulated activated calcium (CRAC) channels Defect in ORAI1- essential CRAC component 7

Mechanism of impaired NFAT T-cell receptor crosslinking Activation of T-cell Activation of phospholipase Cγ (PLCγ) Inositol-1,4,5 trisphosphate release Defect in essential ORAI1 subunit of CRAC channel Ca 2+ released from ER T-cell proliferation Activation of CRAC channels Ca 2+ influx NFAT Mutations in genes required for T-cell development http://www.cdc.gov/genomics/hugenet/reviews/tables/scid_figures.htm 8

Secondary Immunodeficiency Acquired immune deficiency caused by: Malnutrition Malignancy Drugs Trauma Infections Ageing: thymus deterioration no new T cells also affects antibody production Malnutrition Most common cause of 2 o immune deficiency Protein-Calorie malnutrition can lead to abnormalities of T cells, B cells and phagocytes Atrophic and fibrotic thymus Reduced lymphocyte proliferation in response to antigens http://wikieducator.org/images/8/88/kas hiakorchild.jpg 9

Malignancy Immunodeficiency caused by lymphoid tumours e.g. leukaemia, lymphoma, plasma cell dyscrasias Hodgkin s lymphoma: causes classic example of T-cell deficiency Chronic lymphocytic leukaemia: causes classic example of B-cell deficiency Lymphocyte Depletion Hodgkin's Lymphoma http://www.lmp.ualberta.ca/resources/pathoimages/images- H/000p044k.jpg Drugs and Trauma Cytotoxic drugs e.g. azathioprine and cyclophosphamide kill tumour cells but also lymphocytes Corticosteroids Downregulate lymphocytic genes Mimic action of glucocorticoids Glucocorticoids released naturally in response to trauma (burns/surgery) induce immunodeficiency 10

Infections Bacterial e.g. Mycobacterium leprae Tuberculoid leprosy: antibody deficiency Lepromatous leprosy: severe T-cell deficiency Viral Measles transient suppression of NK, T & B cells Herpes (Epstein Barr, HSV, cytomegalovirus) Influenza HIV Ultrastructural appearance of a single virion of measles virus. http://phil.cdc.gov/phil/details.asp HUMAN IMMUNODEFICIENCY VIRUS (HIV) Human retrovirus RNA genome Enveloped (gp41, gp120) Strains M, O, N Targets host cell immune system itself abnormalities in every arm of the immune system 11

REPLICATION OVERVIEW Enters lymphocytes and monocytes. Gp120 recognises CD4 and chemokine receptor (CXR4 or CCR5) Gp 41 binds to heparan sulphate on cell surface, triggering envelope fusion capsid released into cytoplasm 2 types of cell tropism: M-tropic- R5 viruses CCR5 coreceptor T-tropic- X4 viruses CXCR4 coreceptor Viral cdna randomly integrates with host genome. Viral proteins are expressed 12

IMMUNOLOGICAL CONSEQUENCES HIV infection induces: Dysfunction and deficiency of B cells Dysfunction and deficiency of T cells Decreased phagocytosis and intracellular killing by monocytes and neutrophils Decreased cell-mediated cytotoxicity by natural killer cells ultimately leading to severe secondary IMMUNODEFICIENCY HUMORAL IMMUNE RESPONSE B-CELL DYSFUNCTION B-cell hyperplasia depletion Polyclonal hypergammaglobulinemia Autoantibodies Specific antibody response 13

CELLULAR IMMUNE RESPONSE IMMUNE EVASION: Provirus latency, reservoirs, strain switch, MHC downregulation, viral epitope mutation Lymphopenia CD4+ & CD8+ T cells Cytokines T Cell CYTOKINES Switch T H 1 T H 2 cytokine response enables efficient evolution of HIV tropism phenotype R5 X4 T H 1 more CCR5 R5 strain proliferates T H 2 more CXCR4 X4 strain proliferates Alters cytokine secretion (IL1/ 2/ 6/ 7/ 10/ 12, IFNs) E.g. IL-7 favours HIV persistence 14

Summary of Immunodeficiency Immunodeficiency is split into two main categories: primary and secondary. Each has a variety of causes and immunological effects XLA (Primary) Blocked B-cell development: antibody deficiencies. SCIDs (Primary) directly compromises the normal development and function of T-cells and therefore indirectly, B-cells. HIV is an excellent example of a secondary immunodeficiency, affecting every aspect of the human immune system to devastating effect. References 1) Ballow, M., (2002) 'Primary immunodeficiency disorders: Antibody deficiency', Current reviews of allergy and clinical immunology Vol. 109(4): pp581-591 [doi: 10.1067/mai.2002.122466] 2) Maródi, L., & Notarangelo, L.D., (2007) 'Immunological and genetic bases of new primary immunodeficiencies' Nature Reviews - Immunology Vol. 7, November 2007 pp851-860 [doi: 10.1038/nr2195] 3) Gupta, S., & Fernades, G., (2001) 'Immunodeficiency: Secondary' Encyclopedia of Life Sciences 4) Chinen, J., & Shearer, W.T., (2002) 'Molecular virology and immunology of HIV infection' Current reviews of allergy and clinical immunology Vol. 110(2): pp189-198 [doi: 10.1067/mai.2002.126226] 15